Nuclear protein Ki67 suitable as a biomarker for pleural mesothelioma. International study by Karl Landsteiner University of Health Sciences confirms Ki67’s high informative value for tumour aggressiveness and surgical treatment success. Therapy individualization possible.
WeiterlesenPersonalized treatment of malignant tumours according to Ki67
